FDA Approves New Treatment for Opioid Dependence

The sublingual buprenorphine and naloxone combo should be part of a complete treatment plan
Source: The Doctors Lounge - Psychiatry - Category: Psychiatry Tags: Pharmacy, Psychiatry, Anesthesiology & amp; Pain, Institutional, Source Type: news